Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin vs placebo on brain insulin sensitivity in prediabetes
2016-003477-18Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in prediabetes comparing Empagliflozin with Placebo (2 arms). Started Jan 2017; status: completed.
02
Drugs
empagliflozin
03
Conditions
prediabetes
Beyond the preview
Go deeper on 2016-003477-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003477-18.